Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Can B Corp (CANB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: CANB (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -76% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.53M USD | Price to earnings Ratio 0.72 | 1Y Target Price 10 |
Price to earnings Ratio 0.72 | 1Y Target Price 10 | ||
Volume (30-day avg) 308358 | Beta 1.02 | 52 Weeks Range 0.00 - 0.08 | Updated Date 04/1/2025 |
52 Weeks Range 0.00 - 0.08 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -18553.67% |
Management Effectiveness
Return on Assets (TTM) -62.52% | Return on Equity (TTM) -1148.32% |
Valuation
Trailing PE 0.72 | Forward PE 8.85 | Enterprise Value 22176221 | Price to Sales(TTM) 5.35 |
Enterprise Value 22176221 | Price to Sales(TTM) 5.35 | ||
Enterprise Value to Revenue 21.46 | Enterprise Value to EBITDA -2.17 | Shares Outstanding 75842000 | Shares Floating 73208635 |
Shares Outstanding 75842000 | Shares Floating 73208635 | ||
Percent Insiders 3.48 | Percent Institutions 0.98 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Can B Corp
Company Overview
History and Background
Can B Corp (CANB) was initially focused on biomedical services and consumer products. It has since shifted towards the hemp and CBD markets. Information on its founding year and detailed milestones is limited in readily available public sources.
Core Business Areas
- CBD Products: Develops and markets various CBD-infused products, including edibles, topicals, and pet products.
- Vaporizers: Distributes vape hardware and accessories.
Leadership and Structure
Details regarding the specific leadership team and organizational structure are limited in publicly available sources, but available through direct inquiry with Can B Corp.
Top Products and Market Share
Key Offerings
- Pure Leaf Oil: CBD oil products. Market share data specific to Can B Corp for this product is not readily available. Key competitors include Charlotte's Web (CWBHF), and Curaleaf (CURLF).
- Vaporizers: Vape hardware. Market share data specific to Can B Corp for this product is not readily available. Competitors include PAX Labs, JUUL (Altria).
Market Dynamics
Industry Overview
The CBD market is highly competitive and rapidly evolving, with varying regulations across different states and countries. The industry is characterized by numerous small and medium-sized players and increasing consolidation.
Positioning
Can B Corp is a smaller player in the CBD market, facing competition from larger, more established companies with greater brand recognition and distribution networks.
Total Addressable Market (TAM)
The global CBD market is expected to reach billions of dollars in the coming years. Can B Corp is attempting to capture a share of this market through its product offerings, but its current positioning puts it at a disadvantage compared to larger competitors. Estimates put 2024 total CBD market at approximately $5.18 billion in the United States.
Upturn SWOT Analysis
Strengths
- Product diversification into hemp and CBD
- Presence in the growing CBD market
Weaknesses
- Limited brand recognition
- Smaller scale compared to competitors
- Dependence on evolving regulatory environment
- Limited access to capital
Opportunities
- Expansion into new geographic markets
- Development of innovative CBD products
- Strategic partnerships and acquisitions
- Increased legalization of CBD
Threats
- Intense competition
- Changing regulations
- Negative publicity surrounding CBD products
- Economic downturns affecting consumer spending
Competitors and Market Share
Key Competitors
- CWBHF
- CURLF
- SMG
Competitive Landscape
Can B Corp faces significant challenges in competing with larger, more established players in the CBD market. It needs to differentiate itself through innovative products, strategic partnerships, or a strong brand identity.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been inconsistent, reflecting the volatile nature of the CBD market and the company's size.
Future Projections: Future growth prospects are uncertain, dependent on market conditions, regulatory changes, and the company's ability to execute its strategy.
Recent Initiatives: Information on recent strategic initiatives is limited in publicly available sources.
Summary
Can B Corp is a small player in the competitive CBD market, facing challenges related to brand recognition, scale, and regulatory uncertainty. While the company operates in a growth industry, its limited resources and intense competition pose significant risks. Success hinges on its ability to innovate, secure funding, and navigate the evolving regulatory landscape. Public information is also limited making it difficult to gauge the stability and future outlook of the business.
Similar Companies
- CWBHF
- CURLF
- SMG
Sources and Disclaimers
Data Sources:
- SEC filings, company press releases, industry reports, analyst reports (where available), MarketWatch, Yahoo Finance, OTC Markets
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough due diligence and consultation with a qualified financial advisor. Market share data is estimated based on available public information and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Can B Corp
Exchange NASDAQ | Headquaters Hicksville, NY, United States | ||
IPO Launch date 2011-04-29 | Chairman & CEO Mr. Marco Alfonsi | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 12 | Website https://www.canbcorp.com |
Full time employees 12 | Website https://www.canbcorp.com | ||
Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in January 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.